Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study
| dc.contributor.author | Keith, Paul K. | |
| dc.contributor.author | Cowan, Juthaporn | |
| dc.contributor.author | Kanani, Amin | |
| dc.contributor.author | Kim, Harold | |
| dc.contributor.author | Lacuesta, Gina | |
| dc.contributor.author | Lee, Jason K. | |
| dc.contributor.author | Chen, Jie | |
| dc.contributor.author | Park, Michelle | |
| dc.contributor.author | Gladiator, André | |
| dc.date.accessioned | 2023-06-27T03:27:49Z | |
| dc.date.available | 2023-06-27T03:27:49Z | |
| dc.date.issued | 2023-06-23 | |
| dc.date.updated | 2023-06-27T03:27:50Z | |
| dc.identifier.citation | Allergy, Asthma & Clinical Immunology. 2023 Jun 23;19(1):54 | |
| dc.identifier.uri | https://doi.org/10.1186/s13223-023-00805-3 | |
| dc.identifier.uri | https://doi.org/10.20381/ruor-29301 | |
| dc.identifier.uri | http://hdl.handle.net/10393/45095 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | The Author(s) | |
| dc.title | Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study |
